By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Octapharma AG 

Seidenstraße 2

Lachen    CH-8853  Switzerland
Phone: 41-55-451-2121 Fax: 41-55-451-2110



Company News
Octapharma AG Underlines Strong Commitment To Haemophilia A Patients With The Publication Of New Clinical Data On PK-Guided Personalized Prophylaxis According To The Nupreviq Approach With Nuwiq 5/22/2017 7:07:59 AM
Octapharma AG Publishes 2016 Annual Results Reporting Revenue Of €1.6 Billion And Operating Income Of €383 Million 3/1/2017 6:17:32 AM
Octapharma AG Presents Key Data With Nuwiq In Previously Untreated Patients From The Nuprotect Study At American Society of Hematology (ASH) Annual Meeting In San Diego, USA 12/21/2016 11:45:50 AM
Octapharma AG To Sponsor Two Symposia At The 2016 World Federation Of Hemophilia (WFH) World Congress In Orlando, USA 7/22/2016 7:51:30 AM
Zika Virus Guidance From FDA Notes Safety Of Plasma Protein Products And The Availability Of Octapharma AG’s Octaplas 3/7/2016 10:29:16 AM
Octapharma AG Selects IDBS' E-WorkBook 10 2/9/2016 8:16:52 AM
Octapharma AG Invests €80 Million to Acquire an Exclusive Worldwide License to Certain IP of Glycotope’s Technology 10/8/2015 5:58:45 AM
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014 10:55:41 AM
European Commission (EC) Publishes Approval Of Octapharma AG’s Human Cell Line Recombinant FVIII (Nuwiq®) Across All Age Groups In Haemophilia A 8/6/2014 10:12:06 AM
Octapharma AG Sponsors Symposium “Spotlight On The Human Factor: Building A Foundation For The Future Of Haemophilia A Management" At 2014 WFH World Congress In Melbourne, Australia 5/27/2014 7:08:02 AM